Fritextsökning
Innehållstyper
-
Ny ordförande för Labtech
Peter Bräutigam avgår som Swedish Labtechs ordförande och ersätts av Maria Holmlund.
-
Density meters with six-digit precision
The new instruments from Krüss Optronic offer high sensitivity for density measurements.
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Robotlabb som automatiserar allt
Transcriptic är ett nytt koncept och finns tillgängligt som en service. är ett robotiserat start-up företag som ska göra livet på labbet enklare för användaren.
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Diamyds vd går till Index
Från och med april ska Peter Zerhouni leda forskningsbolaget, som bland annat utvecklar läkemedel mot inflammatoriska tarmsjukdomar.
-
Orexo stämmer Actavis
Uppsalabolaget har inlämnat en stämningsansökan mot Actavis för patentintrång avseende Abstral i USA.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Första priset efter rekorddonationen
I maj 2016 donerade Bengt Sjöberg 2 miljarder kronor - en av de största donationerna i svensk historia. Nu delas det första priset i donationens namn ut. Sjöber...
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
GSK:s ebolavaccin får snabbspår i FDA
Nu inleder bolaget patientstudier i friska frivilliga.
-
De får högst forskningsbidrag av Vetenskapsrådet
Jan Nilsson, Leif Groop och Jonas Frisén ska driva de projekt som fick högst bidrag i årets bidragsutdelning inom medicin och hälsa.
-
Han tar rodret på Siemens Healthcare
Tomas Kramar är vd för det nya bolaget som även rekryterat en försäljningschef.
-
Trio goes in for high tech medicines
The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.
-
Eli Lilly writes biotech fine history
The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.
-
New faces in Pronova Biopharma team
The Norwegian company Pronova Biopharma has recently changed the management team structure.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
BREAKING